Forward pharma a/s (FWP)
CashFlow / Yearly
Dec'17Dec'16Dec'15
Operating activities:
(Loss) income before taxes

1,184,488

-54,539

-37,340

Adjustments to reconcile (loss) income before tax to net cash flows from operating activities:
Share - based payment costs

7,082

14,288

13,541

Depreciation expense

227

109

37

Other including foreign exchange rate (gain) and loss

-4,217

986

12,372

Cash outflow for taxes

255,453

-291

-466

Cash inflow for interest

571

1,006

1,451

Decrease in prepayments and other receivables

71

1,526

-4,841

(Decrease) increase in trade and other payables

-1,256

4,200

3,931

Net cash flows (used in) provided by operating activities

939,947

-34,105

-35,127

Investing activities:
Proceeds from the maturity of available-for-sale financial assets

85,368

41,201

43,412

Purchase of equipment

3

31

382

Net cash flows used in investing activities

85,365

41,170

43,030

Financing activities:
Shares issued for cash

49

114

155

Shareholder distribution

1,093,927

-

-

Repurchase of equity awards

24,813

-

-

Net cash flows (used in) provided by financing activities

-1,118,691

114

155

Net (decrease) increase in cash and cash equivalents

-93,379

7,179

8,058

Net foreign exchange differences

145,035

-1,550

-1,138